Speaker illustration

Doctor Brenden Ingraham

Mayo Clinic Hospital-Rochester, Rochester (United States of America)

Genotype-Guided Oral P2Y12 Inhibitor Therapy Reduces Cumulative Ischemic Events Following Percutaneous Coronary Intervention - A Prespecified Secondary Analysis of the TAILOR-PCI Randomised Trial

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Late-Breaking Science - Innovations in drug treatment

Thumbnail

This platform is supported by

logo Novo Nordisk